Aphakia

5

Review clinical trials related to Aphakia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Contralateral Claims Study of Clareon Vivity Pro

The purpose of this study is to test new versions of Clareon Vivity Pro intraocular lenses (IOLs) by comparing them to currently marketed IOLs.

Participants needed: 231
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: Alcon ResearchUpdated: Jun 15, 2026Locations: 9
Eligibility criteria

Cataracts in both eyes. [+3]

Desires monovision correction. [+3]

Status: Recruiting

Clareon TruPlus Study

The purpose of this research study is to generate safety and performance data for Clareon TruPlus Monofocal Intraocular Lenses (IOLs). IOLs are medical devices that are implanted in the eye during cataract surgery to restore clear vision after the cloudy natural lens has been removed. IOLs are intended to remain in the eyes for the duration of the patient's lifetime.

Participants needed: 122
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: Alcon ResearchUpdated: Jun 3, 2026Locations: 5
Eligibility criteria

Diagnosed with bilateral cataracts and planned bilateral cataract extraction by... [+3]

Age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, and othe... [+2]

Status: Recruiting

Feasibility Study of an Accommodating IOL Design

The purpose of this clinical study is to assess safety and explore usability and effectiveness of the test product, AAL-FAIOL. This study will be conducted in Central America.

Participants needed: 85
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: Alcon ResearchUpdated: May 19, 2026Locations: 4
Eligibility criteria

Able to understand and sign an Informed Consent Form. [+4]

Women of childbearing potential who are pregnant, intend to become pregnant duri... [+4]

Status: Not yet recruiting

Clinical Evaluation of a Novel Trifocal IOL

The purpose of this study is to understand the visual outcomes of the investigational intraocular lens (IOL) Model LPYWT0 when compared to the commercially marketed Clareon PanOptix Pro IOL Model PXYWT0.

Participants needed: 66
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: Alcon ResearchUpdated: May 18, 2026Locations: 4
Eligibility criteria

The calculated power needed for the artificial lens (IOL) must be between +15.0... [+3]

Clinically significant corneal diseases which may, according to the investigator... [+4]

Status: Recruiting

Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL

The study purpose is to demonstrate safety and performance of bilateral implantation of LuxBoost intraocular lenses compared with the LuxGood Monofocal lens.

Participants needed: 58
Trial details
Age: 50+Biological sex: AllType: InterventionalSponsor: Cutting Edge SASUpdated: Feb 12, 2026Locations: 2
Eligibility criteria

Subject aged 50 or over on the day of inclusion, presenting a [+10]

Ocular surface disease potentially affecting study results [+9]